Compare Firy Inc. (FIRY) vs Hinge Health Inc. Class A Common Stock (HNGE) Price & Performance
Price performance (Past 24H)
Key statistics
Key statistics
Firy Inc. vs Hinge Health Inc. Class A Common Stock — how do they compare? Firy Inc. trades at $11.27 (market cap $185.67M), while Hinge Health Inc. Class A Common Stock trades at $103.99 (market cap $8.47B). The key difference: Hinge Health Inc. Class A Common Stock is far larger — about 45.6× Firy Inc.'s market cap, and Hinge Health Inc. Class A Common Stock is trading nearer its 52-week high, Firy Inc. nearer its low. Which is the better fit depends on your goals — on Pluang, investors hold Firy Inc. for 13 Days and Hinge Health Inc. Class A Common Stock for 0 Days on average.
| FIRY | HNGE | |
|---|---|---|
Market Cap | $185.67M | $8.47B |
Volume | 194,374 | 1,624,526 |
Sector | Technology | Health |
52-Week High | $13.10 | $105.14 |
52-Week Low | $2.28 | $31.17 |
Typical Hold Time | 13 Days | 0 Days |
Enterprise Value | $154.27M | $8.09B |
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
FIRY trades at $12.41, up 0.16% with a bullish technical signal from moving averages. The company reported Q2 2026 revenue of $31.0M but posted a net loss of -$70.41M for 2025, with negative cash flow of -$86.41M. Recent developments include a $719M legal victory and board appointment of Marc Lasry. Valuation metrics show P/S of 1.65 and P/B of 2.44, while profitability remains challenged with -60.23% net margin.
Despite technical strength, FIRY faces significant fundamental challenges with persistent losses and cash burn. The legal win provides potential upside but collection uncertainty remains. Analyst consensus is mixed with 20% buy, 60% hold ratings. Investment appeal hinges on successful monetization of legal judgment and operational turnaround amid ongoing cash flow concerns.
Hinge Health (HNGE) trades at $105.14, up 0.31% on the day and near its 52-week high. The stock shows strong analyst support with a 93.75% buy rating, though the current price exceeds the consensus target of $101.62. Recent earnings beat expectations in two of the last three quarters, with Q3 2026 results due November 2. Fundamentals indicate robust revenue growth projections from $588 million in 2025 to $720 million in 2026, alongside a shift to profitability, but valuation multiples like EV/EBITDA at 82.33 remain elevated.
The outlook is cautiously optimistic given projected profitability and expansion into migraine and GI care, but risks include high insider selling, competitive pressures, and the stock's premium valuation. Execution on growth targets and Q3 earnings will be critical for sustaining momentum.
Returns comparison
Trailing returns across standard periods
Returns comparison
Trailing returns across standard periods
Investor sentiment on Pluang
What Pluang investors did over the last 30 days
Investor sentiment on Pluang
What Pluang investors did over the last 30 days
No sentiment data available yet.
About Firy Inc.
Firy Inc. operates a mobile gaming platform in the United States, Israel, China, Malta, Hong Kong, Cyprus, and other international markets. The company operates through two segments: Skillz and RZR. Its Skillz platform enables game developers to monetize their content by integrating real-money tournaments, virtual prizes, and social competition features directly into multiplayer games.
Read more on FIRY →About Hinge Health Inc. Class A Common Stock
Hinge Health Inc. operates a digital musculoskeletal (MSK) care platform that delivers exercise therapy for joint and muscle conditions through health plans and employers. Its Precision Motion Technology combines wearable sensors and computer vision to guide patients through clinician-directed physical therapy remotely.
Read more on HNGE →
